Skill

Assessing reported safety and efficacy outcomes Courses

1 course in the current catalog include this skill or topic.

Related Categories

Clinical & Medical (1)Psilocybin Therapy (1)Research & Science (1)

Adjacent Skills

Assess safety and efficacy findings Evaluate outcomes with psychological support Interpret phase 2b clinical trial results Interpretation of clinical trial results Interpreting dose-ranging study data Interpreting dose-response findings Psilocybin Therapy Reading evidence on treatment-resistant depression Review dose-ranging study design Reviewing safety and efficacy findings

Courses Covering Assessing reported safety and efficacy outcomes

No New Dates

COMP360 psilocybin treatment in TRD

By COMPASS Pathways

This page summarises results from COMPASS Pathways' phase 2b trial of investigational COMP360 psilocybin treatment for treatment-resistant depression. The study assessed three doses and reported a significant reduction in depressive symptoms after 25mg with psychological support.

12 weeks

Professional

Price on request

Psilocybin Therapy Clinical & Medical

Assessing reported safety and efficacy outcomes FAQ

What does Assessing reported safety and efficacy outcomes mean in this catalog?

Assessing reported safety and efficacy outcomes is a course skill or topic tag used by the current PsychedelicsCourses dataset. It groups courses that explicitly mention this skill in their listing metadata.

How many courses cover Assessing reported safety and efficacy outcomes?

There are currently 1 course tagged with Assessing reported safety and efficacy outcomes. They span 1 provider.

How should I compare these courses?

Start with format, time commitment, price, credential signals, and provider context. Confirm final enrollment details with the provider.